Scm-Bios Lung Therapeutics Spv, LP

Scm-Bios Lung Therapeutics Spv, LP is a venture capital fund operated by Steelhead Capital Management, Llc and has approximately $4.5 million in assets. The current minimum investment for Scm-Bios Lung Therapeutics Spv, LP is $15000. 12 percent of the fund is owned by fund of funds. Management owns 12 percent of the fund.

Scm-Bios Lung Therapeutics Spv, LP Overview

Fund Type: venture capital  Scm-Bios Lung Therapeutics Spv, LP is a venture capital fund

Private Fund ID: 805-5525441713 Scm-Bios Lung Therapeutics Spv, LP has a private fund ID of 805-5525441713

Fund Manager: Steelhead Capital Management, Llc (Crd# 173440)

Registered Location: Texas, United States

Total Assets: $4.5 million

Minimum Investment: $15000

Scm-Bios Lung Therapeutics Spv, LP Details

Subadviser: No Is Scm-Bios Lung Therapeutics Spv, LP a subadviser

Other Investment Advisers: No other investment advisors

Solicited: No  Does Scm-Bios Lung Therapeutics Spv, LP solicit investments?

Rely on Reg D Exemption: Yes  Does Scm-Bios Lung Therapeutics Spv, LP have a Reg D exemption?

Audited: Yes  Does Scm-Bios Lung Therapeutics Spv, LP shave audited financial statements?

Master Fund: Yes  Is Scm-Bios Lung Therapeutics Spv, LP a master fund?

Feeder Fund: No  Is Scm-Bios Lung Therapeutics Spv, LP a feeder fund?

GAAP: Yes  Does Scm-Bios Lung Therapeutics Spv, LP use GAAP?

Beneficial Owners: 17  17 has 17 beneficial owners.

Management Ownership: 12% 

Fund of Fund Ownership: 16%  

Non-US Ownership: 0%  Non-US ownership in Scm-Bios Lung Therapeutics Spv, LP

Auditor(s): Jtaylor

Broker-Dealer(s):

Custodian(s): Southwest Bank

Administrator(s):

Scm-Bios Lung Therapeutics Spv, LP Charts and Graphs

Total AUM: $4.5 million

column_171} total assets are $4.5 million

Rank: 24472 out of 30967 registered private funds

Minimum Investment: $15000

Scm-Bios Lung Therapeutics Spv, LP has a minimum investment of $15000.

Rank: 24081 out of 30967 registered private funds

Management Ownership: 12%

Scm-Bios Lung Therapeutics Spv, LP is 12% owned by its management.

Rank: 7711 out of 30967 registered private funds